Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2024-06-18 Director's Dealing
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 24 - 2024
Director's Dealing Classification · 1% confidence The document text consists of detailed tables showing daily transactions of shares ('Volume total journalier', 'Prix pondéré moyen journalier d'acquisition', 'Quantité achetée', 'Prix unitaire') by an entity ('IPSEN') involving specific financial instruments and dates (June 2024). The presence of columns like 'Nom du PSI' (Participant System Identifier) and 'Objectif du rachat' (Buyback objective, mentioning 'MAR Regulation Art 5 §2') strongly indicates a regulatory filing detailing insider or company transactions in its own shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance reports.
2024-06-18 French
IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2024
Transaction in Own Shares Classification · 1% confidence The document text consists of detailed tables reporting daily transactions involving the issuer's shares, including the date, volume, price, and market. Specifically, the tables detail 'Total daily volume (in number of shares)' and 'Purpose of the buyback' which mentions 'MAR Regulation Art 5 §2'. This structure is characteristic of mandatory disclosures regarding transactions in a company's own shares, often by directors or for buyback programs. Comparing this content to the definitions, the category 'Transaction in Own Shares (Code: POS)' is the most appropriate fit, as it covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. It is not a Director's Dealing (DIRS) as the transactions appear to be systematic buybacks rather than individual insider trades, and the purpose explicitly mentions buyback regulation.
2024-06-18 English
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2024
Transaction in Own Shares Classification · 1% confidence The document text consists of detailed tables showing daily transactions of shares by an issuer ('IPSEN') on specific dates (e.g., 03/06/2024, 04/06/2024). The tables include volume, price, and specific transaction reference numbers. Furthermore, the second table explicitly mentions an 'Objectif du rachat' (Purpose of repurchase) and lists transactions executed by an intermediary ('Natixis') on behalf of the issuer. This structure is characteristic of regulatory filings reporting insider transactions or transactions in own shares (share buybacks). Since the document details the purchase/acquisition of shares by the company itself ('Objectif du rachat' implies a repurchase program), the most fitting category is 'Transaction in Own Shares' (POS). It is not a general Director's Dealing (DIRS), as the transactions appear to be systematic buybacks rather than individual director trades, and it is not a general announcement (RPA/RNS) because it contains the detailed transaction data itself.
2024-06-11 French
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2024
Director's Dealing Classification · 1% confidence The document text consists of detailed tables showing transactions involving the issuer 'IPSEN' and an 'Investment Services Provider' (Natixis) over specific dates in June 2024. The tables explicitly mention 'Day of transaction', 'Aggregated daily volume (in number of shares)', 'Price per transaction', and crucially, the 'Purpose of buy back' column contains the phrase 'MAR Regulation Art 5 §2'. This structure is characteristic of mandatory regulatory filings disclosing insider transactions or transactions by parties closely associated with the issuer, specifically related to share dealings. The definition for Director's Dealing (DIRS) covers 'Report of personal share transactions by company directors and executives (insider trades)'. While this specific filing might be a broader insider/major shareholder disclosure, the content strongly aligns with reporting personal/related party share transactions, making DIRS the most appropriate fit among the provided options, as it deals with transactions by insiders/related parties.
2024-06-11 English
Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social" (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references French regulatory articles (Code de commerce and AMF General Regulation) and provides a table detailing the total number of shares and the total gross and net voting rights as of May 31, 2024. This content directly relates to changes in the capital structure and voting rights, which aligns best with the 'Share Issue/Capital Change' category (SHA), as it reports the current state of the capital and voting rights based on regulatory requirements, often triggered by monthly updates or significant events affecting the share count.
2024-06-06 French
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states it provides 'Monthly information relative to the total number of voting rights and shares composing the share capital' and references French regulatory articles (AMF). This type of regular disclosure regarding the total share capital and voting rights structure is a specific regulatory filing requirement, often related to capital structure changes or major shareholdings, but it doesn't fit perfectly into the defined categories like DIRS (Director's Dealing) or MRQ (Major Shareholding Notification, which usually concerns crossing thresholds). Since it is a mandatory, periodic disclosure about the capital base, it is best classified as a general Regulatory Filing (RNS) as it is a specific regulatory disclosure that doesn't match the other specialized codes. The content is a direct regulatory disclosure, not an announcement of a report (RPA).
2024-06-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.